Late ADT a Problem in Prostate Cancer

(MedPage Today) -- Late dosing of common luteinizing hormone-releasing hormone (LHRH) agonists used for androgen deprivation therapy (ADT) in prostate cancer occurs frequently, a researcher reported.
Late dosing was particularly common (over 80...